Inflammation as a Target and a Marker of Disease Severity in Coronary Artery Disease
Dr. Tamar Polonsky, assistant professor of medicine, discusses the key factors associated with coronary artery disease and inflammation and addresses the following questions:
- Would treatment with a potent anti-inflammatory medication, in addition to usual care, reduce cardiovascular events?
- Should we measure inflammatory markers to track response to statin therapy?
- Can hsCRP be used to help guide decisions about when to initiate statin therapy for primary prevention?
Published
January 26, 2016
Created by
Related Presenters
Tamar Polonsky, MD Assistant Professor of Medicine
Tamar Polonsky, MD, MSCI, is a general cardiologist. She treats a wide range of cardiac conditions, including coronary artery disease, hypertension, hyperlipidemia (high cholesterol), and valve disease. Dr. Polonsky also specializes in ...